LUCRIN DEPOT

Lucrin Depot Adverse Events Reported to the FDA Over Time

How are Lucrin Depot adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Lucrin Depot, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Lucrin Depot is flagged as the suspect drug causing the adverse event.

Most Common Lucrin Depot Adverse Events Reported to the FDA

What are the most common Lucrin Depot adverse events reported to the FDA?

Death	47 (7.44%)
Disease Progression	21 (3.32%)
Hot Flush	18 (2.85%)
Metastases To Bone	15 (2.37%)
Cardiac Failure	12 (1.9%)
Pulmonary Embolism	12 (1.9%)
Renal Failure	12 (1.9%)
Prostate Cancer	10 (1.58%)
Abdominal Pain	9 (1.42%)
Coma	9 (1.42%)
Malaise	9 (1.42%)
	Show More
Prostatic Specific Antigen Abnormal	9 (1.42%)
Enterovesical Fistula	8 (1.27%)
Injection Site Pain	8 (1.27%)
Weight Decreased	8 (1.27%)
Cerebrovascular Accident	7 (1.11%)
Fatigue	7 (1.11%)
Arrhythmia	6 (.95%)
Bone Pain	6 (.95%)
Drug Ineffective	6 (.95%)
Injection Site Reaction	6 (.95%)
Libido Decreased	6 (.95%)
Metastasis	6 (.95%)
Stress	6 (.95%)
Emphysema	5 (.79%)
Endometriosis	5 (.79%)
Hospitalisation	5 (.79%)
Hyperhidrosis	5 (.79%)
Myocardial Infarction	5 (.79%)
Urinary Tract Infection	5 (.79%)
Acute Coronary Syndrome	4 (.63%)
Acute Myocardial Infarction	4 (.63%)
Diarrhoea	4 (.63%)
Dyspnoea	4 (.63%)
Fracture	4 (.63%)
Herpes Zoster	4 (.63%)
Insomnia	4 (.63%)
Metastases To Liver	4 (.63%)
Oedema Peripheral	4 (.63%)
Pain	4 (.63%)
Pneumonia	4 (.63%)
Prostatic Specific Antigen Increase...	4 (.63%)
Staphylococcal Abscess	4 (.63%)
Therapeutic Response Decreased	4 (.63%)
Urinary Tract Obstruction	4 (.63%)
Cardiopulmonary Failure	3 (.47%)
Clavicle Fracture	3 (.47%)
Contusion	3 (.47%)
Drug Effect Decreased	3 (.47%)
Dysuria	3 (.47%)
Endocarditis Bacterial	3 (.47%)
Fall	3 (.47%)
Headache	3 (.47%)
Hypersensitivity	3 (.47%)
Ill-defined Disorder	3 (.47%)
Injection Site Abscess	3 (.47%)
Injection Site Discomfort	3 (.47%)
Metastases To Lymph Nodes	3 (.47%)
Multi-organ Failure	3 (.47%)
Night Sweats	3 (.47%)
Pemphigoid	3 (.47%)
Thrombosis	3 (.47%)
Transient Ischaemic Attack	3 (.47%)
Tumour Compression	3 (.47%)
Weight Increased	3 (.47%)
Accident	2 (.32%)
Angiopathy	2 (.32%)
Aphasia	2 (.32%)
Atrial Fibrillation	2 (.32%)
Bladder Squamous Cell Carcinoma Sta...	2 (.32%)
Blood Creatinine Increased	2 (.32%)
Blood Glucose Increased	2 (.32%)
Blood Urea Increased	2 (.32%)
Bone Neoplasm Malignant	2 (.32%)
Breast Reconstruction	2 (.32%)
Burning Sensation	2 (.32%)
Cachexia	2 (.32%)
Cardiovascular Insufficiency	2 (.32%)
Constipation	2 (.32%)
Depressed Level Of Consciousness	2 (.32%)
Diabetes Mellitus	2 (.32%)
Diabetic Complication	2 (.32%)
Diabetic Foot	2 (.32%)
Drug Administration Error	2 (.32%)
Drug Exposure During Pregnancy	2 (.32%)
Emotional Distress	2 (.32%)
Erectile Dysfunction	2 (.32%)
Eye Pain	2 (.32%)
Face Oedema	2 (.32%)
Foot Fracture	2 (.32%)
Gait Disturbance	2 (.32%)
Gastroenteritis	2 (.32%)
Haematochezia	2 (.32%)
Haemorrhagic Stroke	2 (.32%)
Hepatic Failure	2 (.32%)
Histology Abnormal	2 (.32%)
Hypoaesthesia	2 (.32%)
Impaired Driving Ability	2 (.32%)
In Vitro Fertilisation	2 (.32%)
Injection Site Ulcer	2 (.32%)
Lung Infection	2 (.32%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Lucrin Depot, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lucrin Depot is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Lucrin Depot

What are the most common Lucrin Depot adverse events reported to the FDA?

Fatal Outcomes	47 (7.44%)
Metastases	30 (4.75%)
Administration Site Reactions	23 (3.64%)
Neurological	21 (3.32%)
Vascular	20 (3.16%)
Infections - Pathogen Unspecified	19 (3.01%)
Renal Disorders	16 (2.53%)
Heart Failures	15 (2.37%)
Central Nervous System Vascular	14 (2.22%)
Injuries	14 (2.22%)
Therapeutic And Nontherapeutic Effe...	14 (2.22%)
	Show More
Coronary Artery	13 (2.06%)
Immunology And Allergy	13 (2.06%)
Bone And Joint Injuries	12 (1.9%)
Pulmonary Vascular	12 (1.9%)
Reproductive Neoplasms Male Maligna...	12 (1.9%)
Respiratory	12 (1.9%)
Gastrointestinal Signs	11 (1.74%)
Physical Examination Topics	11 (1.74%)
Skin Appendage Conditions	11 (1.74%)
Cardiac Arrhythmias	10 (1.58%)
Gastrointestinal Conditions	9 (1.42%)
Bone Disorders	8 (1.27%)
Miscellaneous And Site Unspecified ...	8 (1.27%)
Urinary Tract Signs	8 (1.27%)
Bacterial Infectious	7 (1.11%)
Epidermal And Dermal Conditions	7 (1.11%)
Gastrointestinal Motility And Defec...	7 (1.11%)
Anxiety Disorders	6 (.95%)
Sexual Dysfunctions, Disturbances A...	6 (.95%)
Therapeutic Procedures And Supporti...	6 (.95%)
Embolism And Thrombosis	5 (.79%)
Lower Respiratory Tract Disorders	5 (.79%)
Uterine, Pelvic And Broad Ligament	5 (.79%)
Appetite And General Nutritional	4 (.63%)
Diabetic Complications	4 (.63%)
Eye	4 (.63%)
Genitourinary Tract	4 (.63%)
Mood Disorders	4 (.63%)
Muscle	4 (.63%)
Renal And Urinary Tract Investigati...	4 (.63%)
Sleep Disorders	4 (.63%)
Viral Infectious	4 (.63%)
Allergic Conditions	3 (.47%)
Decreased And Nonspecific Blood Pre...	3 (.47%)
Glucose Metabolism Disorders	3 (.47%)
Headaches	3 (.47%)
Hepatic And Hepatobiliary	3 (.47%)
Lifestyle Issues	3 (.47%)
Medication Errors	3 (.47%)
Mental Impairment	3 (.47%)
Neoplasm Related Morbidities	3 (.47%)
Procedural And Device Related Injur...	3 (.47%)
Respiratory And Mediastinal Neoplas...	3 (.47%)
Vision	3 (.47%)
Anemias Nonhemolytic And Marrow Dep...	2 (.32%)
Breast Therapeutic Procedures	2 (.32%)
Bronchial Disorders	2 (.32%)
Chemical Injury And Poisoning	2 (.32%)
Gastrointestinal Hemorrhages	2 (.32%)
Investigations, Imaging And Histopa...	2 (.32%)
Leukemias	2 (.32%)
Menstrual Cycle And Uterine Bleedin...	2 (.32%)
Metabolic, Nutritional And Blood Ga...	2 (.32%)
Musculoskeletal And Connective Tiss...	2 (.32%)
Neonatal And Perinatal Conditions	2 (.32%)
Obstetric And Gynecological Therape...	2 (.32%)
Penile And Scrotal Disorders	2 (.32%)
Pleural	2 (.32%)
Renal And Urinary Tract Neoplasms M...	2 (.32%)
Respiratory Disorders Congenital	2 (.32%)
Sexual Function And Fertility	2 (.32%)
Skeletal Neoplasms Malignant And Un...	2 (.32%)
Skin And Subcutaneous Tissue	2 (.32%)
Vulvovaginal Disorders	2 (.32%)
Abdominal Hernias And Other Abdomin...	1 (.16%)
Anterior Eye Structural Change, Dep...	1 (.16%)
Arteriosclerosis, Stenosis, Vascula...	1 (.16%)
Benign Neoplasms Gastrointestinal	1 (.16%)
Bone And Joint Therapeutic Procedur...	1 (.16%)
Breast	1 (.16%)
Cardiac And Vascular Investigations	1 (.16%)
Cardiac Disorder Signs	1 (.16%)
Cardiac Valve	1 (.16%)
Depressed Mood Disorders	1 (.16%)
Enzyme	1 (.16%)
Gastrointestinal Neoplasms Benign	1 (.16%)
Hematological And Lymphoid Tissue T...	1 (.16%)
Injuries By Physical Agents	1 (.16%)
Inner Ear And Viiith Cranial Nerve	1 (.16%)
Joint	1 (.16%)
Legal Issues	1 (.16%)
Male Genital Tract Therapeutic Proc...	1 (.16%)
Peritoneal And Retroperitoneal Cond...	1 (.16%)
Personality Disorders	1 (.16%)
Prostatic Disorders	1 (.16%)
Psychiatric And Behavioural Symptom...	1 (.16%)
Skin Vascular Abnormalities	1 (.16%)
Spinal Cord And Nerve Root	1 (.16%)
Thyroid Gland	1 (.16%)
Vascular Hemorrhagic	1 (.16%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Lucrin Depot, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Lucrin Depot is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.